One on One Video with ICON – Kim Boericke

Thought Leader:

Kim Boericke, ICON Commercialization and Outcomes Services

November 19, 2021      

Kim Boericke,  President, ICON Commercialization and Outcomes Services, discusses what is driving a great focus and intensity on outcomes in clinical trials, trends coming in 2022, and the use of real-world data in the rare disease space.

Post a Comment

You must be logged in to post a Comment.

FEEDBACK